Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gracell
Gracell
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Fierce Biotech
Thu, 04/18/24 - 11:11 am
M&A
biotech
AstraZeneca
Merck
Gracell
Harpoon Therapeutics
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
oncology
M&A
AbbVie
Immunogen
Bristol Myers Squibb
Mirati Therapeutics
RayzeBio
Novartis
MorphoSys
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
Gracell
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
BioSpace
Wed, 12/27/23 - 11:08 pm
AstraZeneca
Gracell
cell therapy
M&A
CAR-T beyond cancer? Novartis and others say yes
EP Vantage
Mon, 06/19/23 - 10:19 am
CAR-T
Novartis
Cabaletta Bio
Cartesian Therapeutics
Bristol Myers Squibb
Gracell
Yake Biotechnology
ASH: In next BCMA myeloma race, Gracell dazzles with 100% response rate as Pfizer, BMS place their bets
Fierce Biotech
Mon, 12/12/22 - 10:33 am
ASH 2022
Gracell
CAR-T
Multiple Myeloma
Bristol Myers Squibb
Pfizer
ASCO 2022 – Carvykti casts a long shadow
EP Vantage
Mon, 06/6/22 - 10:01 am
ASCO 2022
Carvykti
CAR-T
Arcellx
Gracell
Oricell
Multiple Myeloma
EHA 2022 preview – some good news at last
EP Vantage
Mon, 05/16/22 - 10:14 am
EHA
Caribou Biosciences
CB-010
Gracell
Autolus
Roche
Curocell
ADC Therapeutics
Mustang Bio
Gracell raises $85M series B to advance cell therapies
BioCentury
Mon, 02/25/19 - 11:31 pm
Gracell
China
cell therapy